SIGA TECHNOLOGIES INC. - COMMON STOCK

TEPOXX (tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

02 янв 2025 07:30:00 Источник Nasdaq GlobeNewswire

Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox Announced

10 дек 2024 16:00:43 Источник Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024

07 ноя 2024 16:05:02 Источник Nasdaq GlobeNewswire

SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results

31 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies

22 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces Agreement to Supply TPOXX® in Morocco

08 окт 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®

21 авг 2024 16:00:00 Источник Nasdaq GlobeNewswire

Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released

15 авг 2024 07:35:00 Источник Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024

01 авг 2024 16:05:00 Источник Nasdaq GlobeNewswire

SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results

25 июл 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX®

19 июл 2024 08:00:00 Источник Nasdaq GlobeNewswire

SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States

17 июн 2024 16:05:00 Источник Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three Months Ended March 31, 2024

07 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results

01 май 2024 17:00:00 Источник Nasdaq GlobeNewswire

SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX®

01 апр 2024 16:05:00 Источник Nasdaq GlobeNewswire

SIGA Names Larry Miller General Counsel

25 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023

12 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

SIGA Declares Special Cash Dividend of $0.60 Per Share

12 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results

05 мар 2024 07:30:00 Источник Nasdaq GlobeNewswire

SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer

22 янв 2024 07:30:00 Источник Nasdaq GlobeNewswire